Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura

Vox Sanguinis

Volumn 105, Issue 3, 2013, Pages 236-243

  van der Lugt, N M ^a   van Kampen, A ^a   Walther, F J ^a   Brand, A ^a   Lopriore, E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Intracranial haemorrhage; Intravenous immunoglobulin; Maternal Idiopathic thrombocytopenic purpura; Neonatal thrombocytopenia; Platelet transfusion; Prednisone.

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISONE; TRANEXAMIC ACID;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; MAJOR CLINICAL STUDY; MATERNAL SERUM; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEONATAL THROMBOCYTOPENIA; NEWBORN; NEWBORN CARE; OUTCOME ASSESSMENT; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SIBLING; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

INTRACRANIAL HAEMORRHAGE; INTRAVENOUS IMMUNOGLOBULIN; MATERNAL IDIOPATHIC THROMBOCYTOPENIC PURPURA; NEONATAL THROMBOCYTOPENIA; PLATELET TRANSFUSION; PREDNISONE.;

ADULT; BLOOD PLATELETS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; PLATELET COUNT; PLATELET TRANSFUSION; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE; RISK FACTORS; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884288937     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12036     Document Type: Article

References (28)

1. Fujimura K, Harada Y, Fujimoto T, et al.: Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 2002; 75:426-433.
2. Webert KE, Mittal R, Sigouin C, et al.: A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003; 102:4306-4311.
3. Sainio S, Joutsi L, Jarvenpaa AL, et al.: Idiopathic thrombocytopenic purpura in pregnancy. Acta Obstet Gynecol Scand 1998; 77:272-277.
4. al-Mofada SM, Osman ME, Kides E, et al.: Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia. Am J Perinatol 1994; 11:423-426
5. Samuels P, Bussel JB, Braitman LE, et al.: Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990; 323:229-235.
6. Yamada H, Kato EH, Kobashi G, et al.: Passive immune thrombocytopenia in neonates of mothers with idiopathic thrombocytopenic purpura: incidence and risk factors. Semin Thromb Hemost 1999; 25:491-496.
7. Valat AS, Caulier MT, Devos P, et al.: Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia. Br J Haematol 1998; 103:397-401.
8. Kaplan C, Daffos F, Forestier F, et al.: Fetal platelet counts in thrombocytopenic pregnancy. Lancet 1990; 336:979-982.
9. Koyama S, Tomimatsu T, Kanagawa T, et al.: Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am J Hematol 2012; 87:15-21.
10. Christiaens GC, Nieuwenhuis HK, Bussel JB: Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol 1997; 90:546-552.
11. Payne SD, Resnik R, Moore TR, et al.: Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 1997; 177:149-155.
12. Cook RL, Miller RC, Katz VL, et al.: Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 1991; 78:578-583.
13. Sharon R, Tatarsky I: Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura. Am J Hematol 1994; 46:87-90.
14. Mazzucconi MG, Petrelli V, Gandolfo GM, et al.: Autoimmune thrombocytopenic purpura in pregnancy: maternal risk factors predictive of neonatal thrombocytopenia. Autoimmunity 1993;16:209-214.
15. Gandemer V, Kaplan C, Quelvennec E, et al.: Pregnancy-associated autoimmune neonatal thrombocytopenia: role of maternal HLA genotype. Br J Haematol 1999; 104:878-885.
16. Christiaens GC, Nieuwenhuis HK, von dem Borne AE, et al.: Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol 1990; 97:893-898.
17. Borna S, Borna H, Khazardoost S: Maternal and neonatal outcomes in pregnant women with immune thrombocytopenic purpura. Arch Iran Med 2006; 9:115-118.
18. Al-Jama FE, Rahman J, Al-Suleiman SA, et al.: Outcome of pregnancy in women with idiopathic thrombocytopenic purpura. Aust N Z J Obstet Gynaecol 1998; 38:410-413.
19. Garmel SH, Craigo SD, Morin LM, et al.: The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura. Prenat Diagn 1995; 15:439-445.
20. Gernsheimer T, McCrae KR: Immune thrombocytopenic purpura in pregnancy. Curr Opin Hematol 2007; 14:574-580.
21. Dutch CBO Guideline Blood Transfusion 2011: Chapter 6.2.3., 2011:231-232.
22. Lescale KB, Eddleman KA, Cines DB, et al.: Antiplatelet antibody testing in thrombocytopenic pregnant women. Am J Obstet Gynecol 1996; 174:1014-1018.
23. OECD Indicators: Caeserean Section: http://www.oecd-ilibraryorg/sites/health_glance-2009-en/04/09/indexhtml?contentType=&itemId=/content/chapter/health_glance-2009-44en&containerItemId=/content/serial/19991312&accessItemIds=/content/book/health_glance2009-en&mimeType=text/html 2013.
24. British Committee for Standards in Haematology General Haematology Task Force: Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120:574-596
25. Lopriore E, Te Pas AB, Steggerda SJ, et al.: Polymicrogyria in a neonate with severe autoimmune thrombocytopenia: rare coincidence or related disorder? Prenat Diagn 2007; 27:87-89.
26. Ballin A, Andrew M, Ling E, et al.: High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr 1988; 112:789-792.
27. Ovali F, Samanci N, Ermis B, et al.: Alternative therapies for neonatal autoimmune thrombocytopenia. Vox Sang 1998; 74:198-200.
28. George JN, Woolf SH, Raskob GE, et al.: Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.